Skip to main content
logo
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
39.90
+2.10 (5.56%)
Jan 21, 2026, 4:08 PM HKT

Revenue by Product

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Animal Models Selling
421.99M
Log In
Log In
Log In
Log In
Upgrade
Animal Models Selling Growth
39.99%
Log In
Log In
Log In
Log In
Upgrade
Antibody Development
344.56M
Log In
Log In
Log In
Log In
Upgrade
Antibody Development Growth
77.30%
Log In
Log In
Log In
Log In
Upgrade
Pre-clinical Pharmacology and Efficacy Evaluation
217.92M
Log In
Log In
Log In
Log In
Upgrade
Pre-clinical Pharmacology and Efficacy Evaluation Growth
1.97%
Log In
Log In
Log In
Log In
Upgrade
Gene-editing
78.15M
Log In
Log In
Log In
Log In
Upgrade
Gene-editing Growth
-4.84%
Log In
Log In
Log In
Log In
Upgrade
Other
415.26K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-27.17%
Log In
Log In
Log In
Log In
Upgrade
Other
415.26K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-27.17%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Other
182.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
53.74%
Log In
Log In
Log In
Log In
Upgrade
United States
536.02M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
61.07%
Log In
Log In
Log In
Log In
Upgrade
China
345.00M
Log In
Log In
Log In
Log In
Upgrade
China Growth
1.17%
Log In
Log In
Log In
Log In
Upgrade
Other
182.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
53.74%
Log In
Log In
Log In
Log In
Upgrade
South Korea
-
Log In
Log In
Log In
Log In
Upgrade